Deleted Tweets From Scott Gottlieb, R-D.C.

We’ve sought to create an efficient regulatory pathway that promotes the more rapid development of genetic tests while assuring their accuracy and clinical relevance. Our efforts will help patients gain access to more sophisticated tests that allow for more targeted medical care.

RT @SecAzar: Last year, the US experienced one of the most severe flu seasons in 40 years. As we recognize National Influenza Va… https://t.co/QB1o1zGUZO

.@ClinGenResource, funded by NIH National Human Genome Research Institute @genome_gov will be a source of valid scientific evidence that can be used to support clinical validity in pre-market submissions for genetic test, including next generation sequencing tests

RT @US_FDA: Today the FDA is recognizing the genetic variant information @ClinGenResource as the first FDA-recognized publicly-… https://t.co/PvCMDRvOug

#FDA will not shy away from calling out instances where we believe some are leveraging tools intended to be useful to instead thwart generic drug competition and thank @FTC for their willingness to work with us on this important issue. https://t.co/osbmLL7GXV

Robust federal partnership will be key to thwarting any efforts to ‘game’ or abuse the system with the intention to thwart generic drug competition. We commend @FTC’s commitment to tackling this issue with #FDA. https://t.co/osbmLL7GXV QT @FTC: FTC submits comment on @US_FDA guidance aimed at deterring abuse of citizen petition process: https://t.co/be0DaVF068)

RT @BioCentury: In a first, FDA recognizes genetic database, removing regulatory hurdle https://t.co/Hgb5BEHA3Y

RT @SeemaCMS: The healthcare industry is ready for complete interoperability and digitization! Our break-out session discussion i… https://t.co/Er3p60YQD0

RT @SGottliebFDA: #FDA advances new policy to encourage more effective engagement with generic drug applicants to improve efficiency… https://t.co/a2YhyO0672

RT @HCA_News: Use of a publicly accessible database may help reduce regulatory burdens on test developers and spur advancements i… https://t.co/dXTI0ZSB4v

The Rule issued today - and steps we announced last week to modernize the 510k pathway - will help #FDA regulate new technologies in ways that enable us to protect patient safety while advancing device innovations that promote peoples’ health and function. https://t.co/EgcEMjUAd0

RT @USDAFoodSafety: Did you catch @USDA’s Meat & Poultry Hotline on @Jeopardy?! I’ll take #BeFOODSafe for 600, Alex! #Jeopardy https://t.co/jBoKzRG34K

The medical device case announced by @TheJusticeDept today is an example of FDA’s comprehensive commitment to ensuring the safety of medical devices and investigating companies that put patients at risk https://t.co/mLQAoADpzi

On a day when we honor President George HW Bush for his many contributions to America, I want to take note of one special contribution he made to the FDA. He led passage of the first FDA user fee legislation, PDUFA 1. In the process began a historic modernization of the agency. https://t.co/eIoP8C5eBb

Today @TheJusticeDept announced agreement for a guilty plea from a medical device company, supported by an FDA criminal investigation; FDA continues to pursue companies that put profits over patient safety https://t.co/mLQAoADpzi

Our new rule creates a more efficient pathway to establish modern predicates to serve as the basis of 510(K) device clearances. It’s part of our effort to help advance a framework that makes sure predicates reflect modern standards for safety, performance. https://t.co/d9Ek3BPkiF

We’re delighted that our beloved squirell monkeys are in a wonderful new home, we’re grateful to their new hosts, and we honor the monkeys for their service and sacrifice in helping the #FDA to advance important public health goals. https://t.co/N3ybie4tqH

RT @statnews: Opinion: The first step to becoming part of a multi-million dollar Facebook scam: answering a pop-up survey asking… https://t.co/yM3p8sprT7

RT @FDAOncology: Discussion of #cancerresearch and NCI-FDA collaboration between @NCIDirector Ned Sharpless, @SGottliebFDA &… https://t.co/AI3sUie4Xi

A common path to addiction to nicotine among kids. It starts with occasional use and then becomes regular use. That’s why even occasional use by kids is so concerning. A child doesn’t start out using an e-cig every day. It starts with sporadic use that then becomes more constant. QT @JeromeAdamsMD: Just spoke w a teacher at my daughters school. Just learned her 18yr old is addicted to e-cigs. Started years ago w… https://t.co/E7qhGYNUSm)

We’ve sought to create an efficient regulatory pathway that promotes the more rapid development of genetic tests while assuring their accuracy and clinical relevance. Our efforts will help patients gain access to more sophisticated tests that allow for more targeted medical care.

RT @SecAzar: Last year, the US experienced one of the most severe flu seasons in 40 years. As we recognize National Influenza Va… https://t.co/QB1o1zGUZO

.@ClinGenResource, funded by NIH National Human Genome Research Institute @genome_gov will be a source of valid scientific evidence that can be used to support clinical validity in pre-market submissions for genetic test, including next generation sequencing tests

RT @US_FDA: Today the FDA is recognizing the genetic variant information @ClinGenResource as the first FDA-recognized publicly-… https://t.co/PvCMDRvOug

#FDA will not shy away from calling out instances where we believe some are leveraging tools intended to be useful to instead thwart generic drug competition and thank @FTC for their willingness to work with us on this important issue. https://t.co/osbmLL7GXV

Robust federal partnership will be key to thwarting any efforts to ‘game’ or abuse the system with the intention to thwart generic drug competition. We commend @FTC’s commitment to tackling this issue with #FDA. https://t.co/osbmLL7GXV QT @FTC: FTC submits comment on @US_FDA guidance aimed at deterring abuse of citizen petition process: https://t.co/be0DaVF068)

RT @BioCentury: In a first, FDA recognizes genetic database, removing regulatory hurdle https://t.co/Hgb5BEHA3Y

RT @SeemaCMS: The healthcare industry is ready for complete interoperability and digitization! Our break-out session discussion i… https://t.co/Er3p60YQD0

RT @SGottliebFDA: #FDA advances new policy to encourage more effective engagement with generic drug applicants to improve efficiency… https://t.co/a2YhyO0672

RT @HCA_News: Use of a publicly accessible database may help reduce regulatory burdens on test developers and spur advancements i… https://t.co/dXTI0ZSB4v

The Rule issued today - and steps we announced last week to modernize the 510k pathway - will help #FDA regulate new technologies in ways that enable us to protect patient safety while advancing device innovations that promote peoples’ health and function. https://t.co/EgcEMjUAd0

RT @USDAFoodSafety: Did you catch @USDA’s Meat & Poultry Hotline on @Jeopardy?! I’ll take #BeFOODSafe for 600, Alex! #Jeopardy https://t.co/jBoKzRG34K

The medical device case announced by @TheJusticeDept today is an example of FDA’s comprehensive commitment to ensuring the safety of medical devices and investigating companies that put patients at risk https://t.co/mLQAoADpzi

On a day when we honor President George HW Bush for his many contributions to America, I want to take note of one special contribution he made to the FDA. He led passage of the first FDA user fee legislation, PDUFA 1. In the process began a historic modernization of the agency. https://t.co/eIoP8C5eBb

Today @TheJusticeDept announced agreement for a guilty plea from a medical device company, supported by an FDA criminal investigation; FDA continues to pursue companies that put profits over patient safety https://t.co/mLQAoADpzi

Our new rule creates a more efficient pathway to establish modern predicates to serve as the basis of 510(K) device clearances. It’s part of our effort to help advance a framework that makes sure predicates reflect modern standards for safety, performance. https://t.co/d9Ek3BPkiF

We’re delighted that our beloved squirell monkeys are in a wonderful new home, we’re grateful to their new hosts, and we honor the monkeys for their service and sacrifice in helping the #FDA to advance important public health goals. https://t.co/N3ybie4tqH

RT @statnews: Opinion: The first step to becoming part of a multi-million dollar Facebook scam: answering a pop-up survey asking… https://t.co/yM3p8sprT7

RT @FDAOncology: Discussion of #cancerresearch and NCI-FDA collaboration between @NCIDirector Ned Sharpless, @SGottliebFDA &… https://t.co/AI3sUie4Xi

A common path to addiction to nicotine among kids. It starts with occasional use and then becomes regular use. That’s why even occasional use by kids is so concerning. A child doesn’t start out using an e-cig every day. It starts with sporadic use that then becomes more constant. QT @JeromeAdamsMD: Just spoke w a teacher at my daughters school. Just learned her 18yr old is addicted to e-cigs. Started years ago w… https://t.co/E7qhGYNUSm)